Status: current, Defined. Date: 30-Sep 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4172921000168114 | Tecentriq (atezolizumab 840 mg / 14 mL) injection, 1 x 14 mL vial (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4172931000168112 | Tecentriq 840 mg/14 mL injection, 14 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tecentriq 840 mg/14 mL injection, 14 mL vial | Is a | atezolizumab 840 mg/14 mL injection, 14 mL vial | true | Inferred relationship | Some | ||
| Tecentriq 840 mg/14 mL injection, 14 mL vial | Is a | trade product pack | true | Inferred relationship | Some | ||
| Tecentriq 840 mg/14 mL injection, 14 mL vial | has TPUU | Tecentriq 840 mg/14 mL injection, 14 mL vial | true | Inferred relationship | Some | 1 | |
| Tecentriq 840 mg/14 mL injection, 14 mL vial | has TP | Tecentriq | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tecentriq 840 mg/14 mL injection, 14 mL vial | Is a | True | Tecentriq 840 mg/14 mL injection, 14 mL vial | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR